罗库溴铵与琥珀胆碱用于快速序贯诱导插管的Cochrane系统评价
该系统评价纳入50项随机或对照临床试验共4151例患者,比较罗库溴铵(≥0.6 mg.kg-1)与琥珀胆碱(≥1 mg.kg-1)在快速序贯插管中的插管条件。总体琥珀胆碱在实现极佳插管条件和临床可接受插管条件方面均优于罗库溴铵,但证据质量因检测偏倚和高异质性为中等。
要点
- 琥珀胆碱在快速序贯插管中实现极佳插管条件优于罗库溴铵(RR 0.86,95%CI 0.81-0.92)。
- 临床可接受插管条件琥珀胆碱也优于罗库溴铵(RR 0.97,95%CI 0.95-0.99)。
- 使用硫喷妥钠诱导时琥珀胆碱优势更明显(RR 0.81,95%CI 0.73-0.88)。
核心结论
- 总体琥珀胆碱在快速序贯插管中实现极佳和临床可接受插管条件均优于罗库溴铵。
- 证据质量因检测偏倚和高异质性为中等。
研究设计与样本
- Cochrane系统评价,检索CENTRAL(2015年第2期)、MEDLINE(1966年至2015年2月第2周)和EMBASE(1988年至2015年2月14日)。
- 纳入报告罗库溴铵(≥0.6 mg.kg-1)与琥珀胆碱(≥1 mg.kg-1)快速或改良快速序贯插管条件的随机对照试验或对照临床试验。
- 共识别66项研究,纳入50项,代表4151例参与者。
主要发现
- 琥珀胆碱在实现极佳插管条件方面优于罗库溴铵:风险比(95%CI)0.86(0.81-0.92),n=4151。
- 琥珀胆碱在实现临床可接受插管条件方面优于罗库溴铵:风险比(95%CI)0.97(0.95-0.99),n=3992。
- 使用硫喷妥钠作为诱导剂时,琥珀胆碱更可能产生极佳插管条件:风险比(95%CI)0.81(0.73-0.88),n=2302,无论是否使用阿片类药物(风险比(95%CI)0.85(0.78-0.93),n=2292;或0.85(0.76-0.95),n=1428)。
局限性
- 试验中检测偏倚发生率高,且存在显著异质性,导致上述结论的证据质量为中等。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This systemic review was performed to determine whether rocuronium creates intubating conditions comparable to those of succinylcholine during rapid sequence intubation of the trachea. We searched the Cochrane Central Register of Controlled Trials (CENTRAL; 2015, Issue 2), MEDLINE (1966 to February Week 2 2015), and EMBASE (1988 to February 14 2015) for any randomised controlled trials or controlled clinical trials that reported intubating conditions comparing rocuronium and succinylcholine for rapid or modified rapid sequence intubation. The dose of rocuronium was at least 0.6 mg.kg-1 and succinylcholine was at least 1 mg.kg-1 . Sixty-six studies were identified and 50 included, representing 4151 participants. Overall, succinylcholine was superior to rocuronium for achieving excellent intubating conditions (risk ratio (95%CI) 0.86 (0.81 to 0.92), n = 4151) and clinically acceptable intubation conditions (risk ratio (95%CI) 0.97 (0.95-0.99), n = 3992). A high incidence of detection bias amongst the trials coupled with significant heterogeneity means that the quality of evidence was moderate for these conclusions. Succinylcholine was more likely to produce excellent intubating conditions when using thiopental as the induction agent: risk ratio (95%CI) 0.81 (0.73-0.88), n = 2302) with or without the use of opioids (risk ratio (95%CI) 0.85 (0.78-0.93), n = 2292 or 0.85 (0.76-0.95), n = 1428).
引用
- Tran DTT, Newton EK, Mount VAH, et al. Rocuronium vs. succinylcholine for rapid sequence intubation: a Cochrane systematic review. Anaesthesia. 2017. PMID: 28654173. doi:10.1111/anae.13903
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。